Login to Your Account

Other News To Note

Monday, July 11, 2011
Marina Biotech Inc., of Bothell, Wash., said preclinical data showed a miRNA mimetic formulated using its liposomal-based delivery technology, SMARTICLES, demonstrated inhibition of tumor growth in an orthotopic liver tumor, as indicated by a decrease in systemic liver tumor biomarker alpha-feto protein and a decrease in tumor weight of more than 80 percent.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription